An active metabolite of nicotine and nAChR agonist
Related Products
Labeled Version(s)
35242(±)-Nornicotine-d4
Parent Compound(s)
16535(±)-Nicotine
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

(±)-Nornicotine

Item No. 20505

Technical Information
Formal Name
3-(2-pyrrolidinyl)-pyridine
CAS Number
5746-86-1
Synonyms
  • DL-Nornicotine
  • (R,S)-Nornicotine
Molecular Formula
C9H12N2
Formula Weight
Purity
≥95%
Formulation
A neat oil
DMF: 50 mg/mlDMSO: 30 mg/mlEthanol: 50 mg/mlPBS (pH 7.2): 1 mg/ml
λmax
262 nm
SMILES
C1(C2CCCN2)=CC=CN=C1
InChi Code
InChI=1S/C9H12N2/c1-3-8(7-10-5-1)9-4-2-6-11-9/h1,3,5,7,9,11H,2,4,6H2
InChi Key
MYKUKUCHPMASKF-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    (±)-Nornicotine is an active metabolite of nicotine (Item No. 16535) and a nicotinic acetylcholine receptor (nAChR) agonist.1 It induces currents in Xenopus oocytes expressing human α7 nAChRs or α6 subunit-containing nAChRs (EC50s = 17 and 3.7 µM, respectively). (±)-Nornicotine promotes cell migration and destabilizes cell-cell junctions in EA.hy926 endothelial cells.2 It is self-administered in rats.3,4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Papke, R.L., Dwoskin, L.P., and Crooks, P.A. The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: Relevance to nicotine dependence and drug discovery. J. Neurochem. 101(1), 160-167 (2007).

    2. Gagat, M., Grzanka, D., Izdebska, M., et alNornicotine impairs endothelial cell-cell adherens junction complexes in EA.hy926 cell line via structural reorganization of F-actin. Folia Histochem. Cytobiol. 51(3), 179-192 (2013).

    3. Bardo, M.T., Green, T.A., Crooks, P.A., et alNornicotine is self-administered intravenously by rats. Psychopharmacology (Berl) 146(3), 290-296 (1999).

    4. Hoffman, A.C., and Evans, S.E. Abuse potential of non-nicotine tobacco smoke components: Acetaldehyde, nornicotine, cotinine, and anabasine. Nicotine Tob. Res. 15(3), 622-632 (2013).